Modulating the modulators: regulation of protein arginine methyltransferases by post-translational modifications

Antja Voy Hartley, Tao Lu

Research output: Contribution to journalReview article

Abstract

The therapeutic potential of targeting protein arginine methyltransferases (PRMTs) is inextricably linked to their key roles in various cellular functions, including splicing, proliferation, cell cycle regulation, differentiation, and DNA damage signaling. Unsurprisingly, the development of inhibitors against these enzymes has become a rapidly expanding research area. However, effective targeting of PRMTs requires a deeper understanding of the mechanistic details behind their regulation at multiple levels, involving those mechanisms that alter their activity, interactions, and localization. Recently, post-translational modifications (PTMs) of PRMTs have emerged as another crucial aspect of this regulation. Here, we review the regulatory role of PTMs in the activity and function of PRMTs, with emphasis on the contribution of these PTMs to pathological states, such as cancer.

Original languageEnglish (US)
JournalDrug Discovery Today
DOIs
StateAccepted/In press - 2020

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Modulating the modulators: regulation of protein arginine methyltransferases by post-translational modifications'. Together they form a unique fingerprint.

  • Cite this